Changes in brain cholinesterases in senile dementia of Alzheimer type
- PMID: 703927
- DOI: 10.1111/j.1365-2990.1978.tb00545.x
Changes in brain cholinesterases in senile dementia of Alzheimer type
Abstract
Acetyl- and butyryl-cholinesterase activities have been measured biochemically in normal brain tissue, in senile dementia of Alzheimer type and in mental disorders without Alzheimer-type abnormalities. Acetylcholinesterase was significantly reduced and butyrylcholinesterase significantly increased, compared with the normal, in the hippocampus and temporal cortex of the Alzheimer cases. No significant enzyme changes were seen in the other diseases investigated including multi-infarct dementia, schizophrenia and depression. There was no correlation between age and acetylcholinesterase activity, but a significant positive correlation between the butyrylcholinesterase activities with increasing age (60-90 years) was found in the hippocampus. The possible connection between cholinergic system pathology and these cholinesterase abnormalities in Alzheimer dementia is discussed.
Similar articles
-
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.Br Med J. 1978 Nov 25;2(6150):1457-9. doi: 10.1136/bmj.2.6150.1457. Br Med J. 1978. PMID: 719462 Free PMC article.
-
Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type.Biol Psychiatry. 1985 Jun;20(6):605-10. doi: 10.1016/0006-3223(85)90095-2. Biol Psychiatry. 1985. PMID: 3995108
-
Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.Brain Res. 1989 Sep 25;498(1):185-9. doi: 10.1016/0006-8993(89)90419-8. Brain Res. 1989. PMID: 2790472
-
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.Int J Neuropsychopharmacol. 2006 Feb;9(1):101-24. doi: 10.1017/S1461145705005833. Epub 2005 Aug 5. Int J Neuropsychopharmacol. 2006. PMID: 16083515 Review.
-
Status of cholinesterase activities in blood in neuropsychiatric disorders.Neurochem Res. 1984 Jul;9(7):863-9. doi: 10.1007/BF00964519. Neurochem Res. 1984. PMID: 6390233 Review.
Cited by
-
Modulatory role of simvastatin against aluminium chloride-induced behavioural and biochemical changes in rats.Behav Neurol. 2015;2015:210169. doi: 10.1155/2015/210169. Epub 2015 Jan 31. Behav Neurol. 2015. PMID: 25802481 Free PMC article.
-
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.J Neural Transm (Vienna). 2006 Nov;113(11):1625-44. doi: 10.1007/s00702-006-0579-2. Epub 2006 Oct 13. J Neural Transm (Vienna). 2006. PMID: 17039298 Review.
-
Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.Pharmacogenet Genomics. 2009 Aug;19(8):635-46. doi: 10.1097/FPC.0b013e32832f8c17. Pharmacogenet Genomics. 2009. PMID: 19617863 Free PMC article. Clinical Trial.
-
Profiling donepezil template into multipotent hybrids with antioxidant properties.J Enzyme Inhib Med Chem. 2018 Dec;33(1):583-606. doi: 10.1080/14756366.2018.1443326. J Enzyme Inhib Med Chem. 2018. PMID: 29529892 Free PMC article. Review.
-
CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment.Front Aging Neurosci. 2021 Aug 26;13:704583. doi: 10.3389/fnagi.2021.704583. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34512307 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources